Patents by Inventor Jiuhong Zha

Jiuhong Zha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
    Publication number: 20240091248
    Abstract: Provided herein are methods for treating acute myeloid leukemia (AML) in a patient with cytopenia when on a combination therapy of venetoclax and azacitidine. Also provided herein are methods of managing a cytopenia in such patient.
    Type: Application
    Filed: November 3, 2023
    Publication date: March 21, 2024
    Applicants: GENENTECH, INC., ABBVIE INC.
    Inventors: Ahmed Hamed SALEM, Jalaja POTLURI, Jiuhong ZHA, Mehrdad MOBASHER, Wan-Jen HONG
  • METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
    Publication number: 20230027184
    Abstract: Provided herein are methods for treating acute myeloid leukemia (AML) in a patient with cytopenia when on a combination therapy of venetoclax and azacitidine. Also provided herein are methods of managing a cytopenia in such patient.
    Type: Application
    Filed: September 15, 2022
    Publication date: January 26, 2023
    Applicants: GENENTECH, INC., ABBVIE INC.
    Inventors: Ahmed Hamed SALEM, Jalaja POTLURI, Jiuhong ZHA, Mehrdad MOBASHER, Wan-Jen HONG
  • METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA
    Publication number: 20230000889
    Abstract: Provided herein are methods for treating acute myeloid leukemia (AML) in a patient with cytopenia when on a combination therapy of venetoclax and azacitidine. Also provided herein are methods of managing a cytopenia in such patient.
    Type: Application
    Filed: June 7, 2022
    Publication date: January 5, 2023
    Applicants: GENENTECH, INC., ABBVIE INC.
    Inventors: Ahmed Hamed SALEM, Jalaja POTLURI, Jiuhong ZHA, Mehrdad MOBASHER, Wan-Jen HONG
  • VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH A CYP3A INHIBITOR AND AZACITIDINE
    Publication number: 20220370481
    Abstract: The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (MDS).
    Type: Application
    Filed: May 10, 2022
    Publication date: November 24, 2022
    Applicant: ABBVIE INC.
    Inventors: John HAYSLIP, Steve H. KYE, Ahmed SALEM, Jiuhong ZHA
  • Dose Adjustment
    Publication number: 20150209403
    Abstract: This application features dose adjustment for drugs co-administered with Compound 1, Compound 2 and/or Compound 3.
    Type: Application
    Filed: January 27, 2015
    Publication date: July 30, 2015
    Inventors: Walid M. Awni, Prajakta Badri, Daniel E. Cohen, Sandeep Dutta, Amit Khatri, Rajeev M. Menon, Thomas Podsadecki, Akshanth Polepally, Roger Trinh, Tianli Wang, Jiuhong Zha
  • PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20140221424
    Abstract: The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and pharmaceutical compositions thereof for the treatment of cystic fibrosis, in patients, including kits and/or products thereof.
    Type: Application
    Filed: January 30, 2014
    Publication date: August 7, 2014
    Inventor: Jiuhong Zha